EU Clinical Trial Debate Moves Onto Patient Centricity, Social Listening And Off-Label Use
This article was originally published in SRA
Executive Summary
As well as being a valuable forum for CROs, pharma firms and service providers to network and talk collaboration, this year's Informa Partnerships in Clinical Trials meeting, held in Hamburg, Germany, saw a host of presentations on some very topical regulatory issues1.